NASDAQ: PBYI
Puma Biotechnology Inc Stock Ownership - Who owns Puma Biotechnology?

Insider buying vs selling

Have Puma Biotechnology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael Patrick MillerDirector2024-08-1223,358$3.49
$81.47kSell
Maximo F. NouguesChief Financial Officer2024-07-174,156$3.70
$15.38kSell
Douglas M. HuntOfficer2024-07-173,637$3.70
$13.46kSell
Alan H. AuerbachPresident and CEO2024-07-1721,920$3.70
$81.13kSell
Jeffrey Jerome LudwigChief Commercial Officer2024-07-172,598$3.70
$9.62kSell
Alan H. AuerbachPresident and CEO2024-07-0218,885$3.27
$61.72kSell
Jeffrey Jerome LudwigChief Commercial Officer2024-07-026,051$3.27
$19.77kSell
Maximo F. NouguesChief Financial Officer2024-07-025,295$3.27
$17.30kSell
Douglas M. HuntOfficer2024-07-024,349$3.27
$14.21kSell
Troy Edward WilsonDirector2024-06-1327,000$3.33
$89.91kSell

1 of 2

PBYI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PBYI insiders and whales buy or sell their stock.

PBYI Shareholders

What type of owners hold Puma Biotechnology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adage Capital Partners GP LLC18.09%8,879,139$27.26MInsider
Alan H. Auerbach14.39%7,063,515$21.68MInsider
Blackrock Inc 17.80%3,827,223$11.75MInstitution
Vanguard Group Inc7.41%3,636,191$11.16MInstitution
Adage Capital Partners LP6.52%3,200,000$9.82MInsider
Frazier Life Sciences Management LP6.24%3,062,558$9.40MInstitution
Millennium Management LLC5.87%2,880,888$8.84MInstitution
Acadian Asset Management LLC4.01%1,968,999$6.04MInstitution
Renaissance Technologies LLC3.61%1,772,413$5.44MInstitution
Eversept Partners LP2.63%1,293,257$3.97MInstitution

1 of 3

PBYI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PBYI58.13%41.87%Net Selling
ATOS21.74%15.16%Net Buying
IFRX21.85%0.00%
SAVA28.53%71.47%Net BuyingNet Selling
ACHV49.23%27.77%Net Buying

Puma Biotechnology Stock Ownership FAQ

Who owns Puma Biotechnology?

Puma Biotechnology (NASDAQ: PBYI) is owned by 60.59% institutional shareholders, 43.64% Puma Biotechnology insiders, and 0.00% retail investors. Adage Capital Partners GP LLC is the largest individual Puma Biotechnology shareholder, owning 8.88M shares representing 18.09% of the company. Adage Capital Partners GP LLC's Puma Biotechnology shares are currently valued at $27.70M.

If you're new to stock investing, here's how to buy Puma Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.